SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in US FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System

As part of the U.S. Food and Drug Administration COVID-19 vaccine review process, public commentary was solicited offering an opportunity to reflect on vaccine attitudes that may impact the uptake of coronavirus vaccines. We identified themes in the commentary that highlighted the safety, efficacy, ethics, and trustworthiness and transparency regarding the novel mRNA COVID-19 vaccines. A Learning Immunization System model is proposed to optimize public, private, and academic partnerships relating to vaccine development and implementation.

Automated summary

The study found that public attitudes towards the safety, efficacy, ethics, trustworthiness and transparency of novel mRNA COVID-19 vaccines are important factors that may impact vaccine uptake. A proposed Learning Immunization System model aims to optimize partnerships between public, private, and academic sectors in vaccine development and implementation.